mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.06 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.06 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.06 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.06 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.06 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.07 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.07 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.07 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.07 |